Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 54.04
-0.72 (-1.31%)
Mar 10, 2026, 1:35 PM CST
Cathay Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 39,463 | 35,889 | 22,555 | 32,012 | 35,749 | 76,786 | Upgrade
|
| Market Cap Growth | 57.51% | 59.12% | -29.54% | -10.45% | -53.44% | 116.67% | Upgrade
|
| Enterprise Value | 34,353 | 30,779 | 22,818 | 31,823 | 33,878 | 71,142 | Upgrade
|
| Last Close Price | 54.76 | 49.80 | 38.48 | 54.26 | 60.32 | 128.99 | Upgrade
|
| PE Ratio | 65.98 | 63.44 | 46.13 | 87.34 | 64.61 | 129.11 | Upgrade
|
| Forward PE | 47.83 | 29.61 | 29.61 | 46.74 | 89.61 | 89.61 | Upgrade
|
| PS Ratio | 11.98 | 10.89 | 7.63 | 15.14 | 14.65 | 32.49 | Upgrade
|
| PB Ratio | 1.86 | 1.69 | 1.49 | 2.17 | 2.38 | 5.23 | Upgrade
|
| P/TBV Ratio | 2.33 | 2.12 | 2.08 | 3.06 | 3.52 | 7.77 | Upgrade
|
| P/OCF Ratio | - | - | 27.48 | 56.22 | 44.48 | 132.69 | Upgrade
|
| EV/Sales Ratio | 10.42 | 9.34 | 7.71 | 15.05 | 13.88 | 30.10 | Upgrade
|
| EV/EBITDA Ratio | 36.12 | 32.36 | 33.56 | 70.52 | 50.43 | 106.53 | Upgrade
|
| EV/EBIT Ratio | 54.09 | 48.46 | 62.70 | 192.23 | 83.32 | 142.50 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.13 | 0.12 | 0.08 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.29 | 0.29 | 2.79 | 3.94 | 1.68 | 1.11 | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.23 | -0.24 | -0.34 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.18 | -9.18 | -5.07 | -8.01 | -7.69 | -13.31 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 154.13 | 3.61 | 1.52 | 10.09 | Upgrade
|
| Asset Turnover | - | - | 0.16 | 0.12 | 0.14 | 0.17 | Upgrade
|
| Inventory Turnover | - | - | 1.60 | 1.01 | 1.17 | 1.56 | Upgrade
|
| Quick Ratio | - | - | 1.99 | 1.70 | 4.75 | 8.14 | Upgrade
|
| Current Ratio | - | - | 2.53 | 2.22 | 5.95 | 9.36 | Upgrade
|
| Return on Equity (ROE) | 3.12% | 3.12% | 3.18% | 2.74% | 4.12% | 4.84% | Upgrade
|
| Return on Assets (ROA) | - | - | 1.20% | 0.56% | 1.49% | 2.20% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.56% | 4.71% | 2.76% | 1.43% | 4.57% | 7.95% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 2.30% | 1.10% | 2.50% | 3.30% | Upgrade
|
| Earnings Yield | 1.43% | 1.58% | 2.17% | 1.15% | 1.55% | 0.78% | Upgrade
|
| FCF Yield | - | - | -0.10% | -3.13% | -9.50% | -1.15% | Upgrade
|
| Dividend Yield | 0.76% | - | 1.04% | 0.35% | 0.30% | 0.25% | Upgrade
|
| Payout Ratio | - | - | 28.80% | 37.58% | 37.39% | 57.11% | Upgrade
|
| Buyback Yield / Dilution | -17.09% | -17.09% | -0.05% | 0.10% | 0.11% | -7.38% | Upgrade
|
| Total Shareholder Return | -16.34% | -17.09% | 0.99% | 0.45% | 0.41% | -7.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.